[go: up one dir, main page]

TWI367756B - A film-coated drug product comprising dextrose - Google Patents

A film-coated drug product comprising dextrose

Info

Publication number
TWI367756B
TWI367756B TW095117777A TW95117777A TWI367756B TW I367756 B TWI367756 B TW I367756B TW 095117777 A TW095117777 A TW 095117777A TW 95117777 A TW95117777 A TW 95117777A TW I367756 B TWI367756 B TW I367756B
Authority
TW
Taiwan
Prior art keywords
dextrose
film
drug product
coated drug
coated
Prior art date
Application number
TW095117777A
Other languages
English (en)
Chinese (zh)
Other versions
TW200719888A (en
Inventor
Takeshi Hamaura
Susumu Hasegawa
Original Assignee
Sankyo Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sankyo Co filed Critical Sankyo Co
Publication of TW200719888A publication Critical patent/TW200719888A/zh
Application granted granted Critical
Publication of TWI367756B publication Critical patent/TWI367756B/zh

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Child & Adolescent Psychology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
TW095117777A 2005-05-20 2006-05-19 A film-coated drug product comprising dextrose TWI367756B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2005147435 2005-05-20

Publications (2)

Publication Number Publication Date
TW200719888A TW200719888A (en) 2007-06-01
TWI367756B true TWI367756B (en) 2012-07-11

Family

ID=37431334

Family Applications (1)

Application Number Title Priority Date Filing Date
TW095117777A TWI367756B (en) 2005-05-20 2006-05-19 A film-coated drug product comprising dextrose

Country Status (5)

Country Link
JP (1) JP4979577B2 (ja)
KR (1) KR101314439B1 (ja)
CN (1) CN101180052B (ja)
TW (1) TWI367756B (ja)
WO (1) WO2006123766A1 (ja)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5241503B2 (ja) * 2006-10-25 2013-07-17 第一三共株式会社 包装材
TWI414310B (zh) * 2006-12-26 2013-11-11 Daiichi Sankyo Co Ltd 溶出性改善之醫藥品組成物
TW200833325A (en) * 2006-12-26 2008-08-16 Daiichi Sankyo Co Ltd Pharmaceutical composition comprising ascorbic acid
JP2008201711A (ja) * 2007-02-20 2008-09-04 Ss Pharmaceut Co Ltd システイン臭が低減された固形製剤
JPWO2009057569A1 (ja) * 2007-10-29 2011-03-10 第一三共株式会社 フィルムコーティング製剤
JP5688799B2 (ja) * 2008-08-11 2015-03-25 第一三共株式会社 におい抑制方法
JP4803686B2 (ja) * 2010-08-31 2011-10-26 協和発酵キリン株式会社 苦味を呈する薬物を含有する顆粒および口腔内崩壊錠
CN102716100B (zh) * 2012-07-12 2013-08-07 南京正大天晴制药有限公司 一种含奥美沙坦酯的片剂及其制备方法
JP6360007B2 (ja) * 2015-06-12 2018-07-18 富士フイルム株式会社 薬物含有粒子の製造方法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6419956B1 (en) * 1999-12-30 2002-07-16 Ancile Pharmaceuticals Odor-masking coating for a pharmaceutical preparation
JP4107831B2 (ja) 2000-11-21 2008-06-25 第一三共株式会社 医薬組成物
ES2262689T3 (es) * 2000-11-21 2006-12-01 Sankyo Company, Limited Composicion que contiene un antagonista del receptor de angiotensina ii y un diuretico y su uso para el tratamiento de la hipertension.
JP4647851B2 (ja) * 2001-08-07 2011-03-09 日立マクセル株式会社 カメラモジュール
CA2514921C (en) * 2003-01-31 2013-04-30 Sankyo Company, Limited Combined use of olmesartan medoxomil and azelnidipine or amlodipine for the treatment of arteriosclerosis and hypertension

Also Published As

Publication number Publication date
KR20080008362A (ko) 2008-01-23
KR101314439B1 (ko) 2013-10-07
CN101180052A (zh) 2008-05-14
JPWO2006123766A1 (ja) 2008-12-25
TW200719888A (en) 2007-06-01
JP4979577B2 (ja) 2012-07-18
CN101180052B (zh) 2010-11-17
WO2006123766A1 (ja) 2006-11-23

Similar Documents

Publication Publication Date Title
EP1929990A4 (en) DRUG DONATION
IL188930A0 (en) Medicament dispenser
IL191940A0 (en) Medicament dispenser
GB2438151B (en) A desiccated product
GB0621300D0 (en) Configuring a software product
ZA200703988B (en) Pharmaceutical product
EP1948543A4 (en) DISPENSER OF TABLETS
GB0526332D0 (en) Pharmaceutical product
AU309481S (en) A tablet
TWI367756B (en) A film-coated drug product comprising dextrose
GB2428122B (en) Pharmaceutical product packaging
IL166368A0 (en) Medicament dispenser
GB0601207D0 (en) A camouglaged article
GB0525238D0 (en) Medicament dispenser
GB0608996D0 (en) Drug counter
GB0522473D0 (en) A pharmaceutical formulation
GB2437069B (en) A timber product manufacturing process
GB0521973D0 (en) A packaged product
GB0503593D0 (en) A display article
AU305157S (en) A medication monitor
ZAF200500104S (en) A medication monitor
GB0511055D0 (en) Drug recognition-uk products process-2005-2007
GB0523580D0 (en) A novel medicament
GB0508918D0 (en) Drug dispensing process
GB0525503D0 (en) A bracelet dispenser

Legal Events

Date Code Title Description
MM4A Annulment or lapse of patent due to non-payment of fees